SCHEMBL28599037

SCHEMBL28599037

COc1ccc(-c2ccnc(NC(=O)C3CC3)c2)c([N+](=O)[O-])c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 2/20 0.52
▸ GSK3B P49841 11/20 0.51
▸ CDK1 P06493 3/20 0.51
▸ CDK2 P24941 3/20 0.51
▸ CDK9 P50750 3/20 0.51
▸ CDK3 Q00526 3/20 0.51
▸ CDK5 Q00535 3/20 0.51
▸ GSK3A P49840 3/20 0.51
▸ CCNT1 O60563 2/20 0.51
▸ CCNB1 P14635 2/20 0.51
▸ CCNE1 P24864 2/20 0.51
▸ CCNA1 P78396 2/20 0.51
▸ CDK5R1 Q15078 2/20 0.51
▸ MAPK14 Q16539 2/20 0.48
▸ MAPK8 P45983 2/20 0.48
▸ MAPK10 P53779 2/20 0.48
▸ PIP5K1C O60331 1/20 0.48
▸ TYK2 P29597 1/20 0.48
▸ PIK3C3 Q8NEB9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30081456 0.94 GSK3B (0.52) ABL1GSK3BCDK1CDK2CDK9
SCHEMBL28919538 0.87 GSK3B (0.51) GSK3BCDK1CDK2CDK9CDK3
SCHEMBL28599038 0.87 GSK3B (0.48) GSK3BCDK1CDK2CDK9CDK3
SCHEMBL28599044 0.84 GSK3B (0.51) ABL1GSK3BMAPK14MAPK8MAPK10
SCHEMBL28597204 0.84 GSK3B (0.56) ABL1GSK3BCDK1CDK2CDK9
SCHEMBL28598125 0.84 GSK3B (0.51) ABL1GSK3BGSK3AMAPK14MAPK8
SCHEMBL28611097 0.83 GSK3B (0.58) GSK3BMAPK14MAPK8MAPK10PIP5K1C
SCHEMBL29276352 0.82 MAPT (0.61) MAPK14
SCHEMBL28598189 0.82 GSK3B (0.49) GSK3BMAPK14MAPK8MAPK10PIK3C3
SCHEMBL28606595 0.82 GSK3B (0.54) ABL1GSK3BMAPK14MAPK8MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113072552-B Beta-carboline GSK3 beta/DYRK 1A dual inhibitor, preparation method thereof and application thereof in resisting Alzheimer disease 中国人民解放军北部战区总医院 2022-11-04 — — CN disclosed
CN-113072552-A Beta-carboline GSK3 beta/DYRK 1A dual inhibitor, preparation method thereof and application thereof in resisting Alzheimer disease 中国人民解放军北部战区总医院 2021-07-06 — — CN disclosed
Send feedback